Bristol Myers CEO on second quarter, infrastructure

The CEO of Bristol Myers Squibb discusses the potential impact of an infrastructure deal on corporate taxes and the importance of maintaining global competitiveness. The conversation highlights the company's focus on innovation, resilience during the pandemic, and the significance of vaccination and safety measures. Additionally, the CEO elaborates on business development strategies and the competition for talent in the pharmaceutical industry.

What measures is Bristol Myers Squibb taking to ensure the safety of its workforce during the pandemic?

What strategies does Bristol Myers Squibb employ for business development?

How is Bristol Myers Squibb addressing the competition for talent in the industry?